Vivo Capital VIII, LLC

CIK 1618789 · last filed 2023-12-19

Vivo Capital VIII, LLC is a corporate insider who has filed 10 SEC Form 4 insider transactions across 6 companies since 2017. Across all open-market trades the lifetime net is −$20.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$7.91M

Companies

6

Total Filings

10

Lifetime Open-Market Net

-$20.07M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BOLT 10%+ Owner 143,571 $4.56 $654.7K -$559.5K 1 2023-11-20
Terns Pharmaceuticals, Inc. (TERN) Delisted 10%+ Owner 281,223 $52.95 $14.89M $27.50M 1 2022-12-23
IPI Legacy Liquidation Co (IMPL) Delisted 10%+ Owner $0.24 $0 1 2021-04-26
Timber Pharmaceuticals, Inc. (BPMX) Delisted 10%+ Owner 317,270 -$1.11M 4 2019-06-27
CRNX 10%+ Owner 210,373 $34.47 $7.25M -$46.39M 1 2019-03-25
Nabriva Therapeutics plc (NBRV) Delisted 10%+ Owner 494,329 $1.42 $701.9K $497.9K 1 2017-09-18

Recent Filings

10 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-12-19 Sell (S) −1,725,000 -$222.4K
2023-11-20 BOLT Sell (S) −602,378 -$559.5K EDGAR
2022-12-23 Terns Pharmaceuticals, Inc. (TERN) Delisted Buy (P) +3,793,100 $27.50M EDGAR
2021-04-26 IPI Legacy Liquidation Co (IMPL) Delisted Other (J) $0 EDGAR
2019-06-27 Timber Pharmaceuticals, Inc. (BPMX) Delisted Sell (S) −327,870 -$334.4K EDGAR
2019-03-25 CRNX Sell (S) −2,085,000 -$46.39M EDGAR
2018-03-09 Timber Pharmaceuticals, Inc. (BPMX) Delisted Sell (S) −2,000,000 -$720.0K EDGAR
2018-01-31 Timber Pharmaceuticals, Inc. (BPMX) Delisted Conv (C) +4,328,571 $0 EDGAR
2017-11-13 Timber Pharmaceuticals, Inc. (BPMX) Delisted Sell (S) −296,394 -$59.3K EDGAR
2017-09-18 Nabriva Therapeutics plc (NBRV) Delisted Buy (P) +52,631 $497.9K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.